Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer.

Julien HadouxRossella EliseiMarcia S BroseAna O HoffBruce G RobinsonMing GaoBarbara JarzabPavel IsaevKaterina KopeckovaJonathan WadsleyDagmar FührerBhumsuk KeamStéphane BardetEric J ShermanMakoto TaharaMimi I HuRavinder SinghYan LinVictoria SoldatenkovaJennifer WrightBoris LinPatricia MaedaJaume CapdevilaLori J Wirthnull null

Published in: The New England journal of medicine (2023)

-mutant medullary thyroid cancer. (Funded by Loxo Oncology, a subsidiary of Eli Lilly; LIBRETTO-531 ClinicalTrials.gov number, NCT04211337.).

Keyphrases

wild type
palliative care